tailored therapies for ibd: a look into the futureprogram symposium 213 tailored therapies for ibd:...

Program

Symposium 213

Tailored Therapies for IBD:A Look into the Future

October 5–6, 2018Milan Marriott HotelMilan, Italy

CME credits 10

Awarded with

3

Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

Scientific Program . . . . . . . . . . . . . . . . . . . . . . . . . 6

Posters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10

List of Speakers, Moderators and Scientific Organizers . . . . . . . . . . . . . . . . . . . . . . . 20

Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

10 credit hours (CME) have been awarded for the Symposium 213 by the European Union of Medical Specialists (UEMS).

4

PrefaceThe mechanisms underlying the chronic intestinal inflammation that is a hallmark of inflammatory bowel diseases (IBD) are complex. Advances in the understanding of IBD pathogenesis have resulted in the development of multiple biological agents that all represent an alternative to the use of current therapies in patients with refractory Crohn‘s disease or ulcerative colitis.

However biomarkers and patient stratification is key to personalize treatment in IBD. As clinicians we may oversimplify the complex nature of IBD and pay not enough attention to the heterogeneity of the pathophysiology and clinical presentation of these disorders. Taking into account specific risk factors, genetic phenotypes, pharmacokinetic characteristics, and other particular features unique to each patient would allow a personalized approach to manage the disease. Personalized medicine therefore represents the tailoring of the medical approach and treatment to the individual characteristics of each patient and is expected to become the paradigm of future healthcare.

The advancements in systems biology research and the rapid development of high-throughput technologies, as well as the characterization of different -omics, will contribute to a shift in modern biological and medical research from traditional hypothesis-driven designs toward data-driven studies and will facilitate the evolution of personalized or precision medicine for chronic diseases such as Crohn’s disease and ulcerative colitis.

The aim of this Falk Symposium is to dive into possibilities of personalized medicine for IBD patients. All speakers and moderators are internationally recognized IBD experts and build the basis for an up-to-date state-of-the-art symposium on IBD. The program is designed to provide opportunities for ample discussion and interaction with speakers, moderators and attendees.

We like to welcome you in Milan, the capital of tailors and designers, which will provide a perfect setup for a meeting on tailored therapies.

S. Danese A. Armuzzi A. Dignass P. Gionchetti

55

Symposium 213

Tailored Therapies for IBD:A Look into the Future

October 5–6, 2018Milan Marriott HotelMilan, Italy

Start of Registration:Thursday, October 4, 201816.00 – 21.00 hat the congress office

Setting Up of Poster Session:Thursday, October 4, 201816.00 – 21.00 h

Congress Venue:Milan Marriott HotelVia Washington 6620146 MilanItaly

Symposium 213 is organized by Falk Foundation e.V.

Scientific Organization:Prof. Dr. Silvio DaneseIRCCS in GastroenterologyIstituto Clinico Humanitas IRCCSVia Manzoni 5620089 RozzanoItalyTelephone: +39-0282-2482-82Telefax: +39-0282-2451-01E-mail: sdanese@hotmail.com

Scientific Co-Organization:A. Armuzzi, Rome (Italy)A. Dignass, Frankfurt (Germany)P. Gionchetti, Bologna (Italy)

Official Language:English

6

Friday, October 5, 2018

9.00 Welcome S. Danese, Milan

Session I Predicting good or bad prognosis

Chair: G. Fiorino, Milan; A. Sturm, Berlin

9.10 Genetic and clinical features for natural history V. Annese, Dubai

9.30 Endoscopy to tailor choices M. Daperno, Turin

9.50 Radiology to predict natural history G. Fiorino, Milan

10.10 Biomarkers and prognosis M.C. Dubinsky, New York

10.30 Coffee break with poster session

Session II Conventional therapies: Optimizing therapies to patient profiles

Chair: J. Lindsay, London; B. Siegmund, Berlin

11.00 Steroids: Old and new formulations S.P.L. Travis, Oxford

11.20 5-ASA in UC: Outdated or still state-of-the-art? A. Dignass, Frankfurt

11.40 Azathioprine: Outdated or still a valid option for F. Baert, UC and CD? Roeselare

12.00 Methotrexate in CD and UC after METEOR F. Carbonnel, Paris

12.20 Lunch break with poster session

7

Friday, October 5, 2018 Session III Anti-TNF: A tailor made approach

Chair: M. Allez, Paris; F. Rizzello, Bologna

14.20 Predicting response: The best patient Y. Chowers, Haifa

14.40 Predicting loss of response I. Dotan, Petah Tikva

15.00 Optimizing anti-TNF therapy M. Ferrante, Leuven

15.20 Tailoring interruption of anti-TNF in IBD E. Louis, Liège

15.40 Coffee break with poster session

Session IV Vedolizumab and ustekinumab

Chair: R. Atreya, Erlangen; S. Schreiber, Kiel

16.10 Vedolizumab in UC: For all patients or best patient profile B.E. Sands, New York

16.30 Vedolizumab in CD: For all patients or best patient profile S. Schreiber, Kiel

16.50 Ustekinumab: Who and when? W.J. Sandborn, La Jolla

17.10 Safety of biologics in IBD: Recent updates S. Bonovas, Milan

17.30 State-of-the-Art Lecture: C. Fiocchi, Predicting the future of treatment for IBD Cleveland

18.00 Scientific discussion with snacks

8

Saturday, October 6, 2018 Session V

New molecules Chair: F.J. Magro, Porto; G. Rogler, Zurich

9.00 JAKs R. Panaccione, Calgary

9.20 New anti-adhesion molecules S. Ghosh, Birmingham

9.40 Sphingosine-1-phosphate receptor modulators in the B.G. Feagan, treatment of IBD London, CA

10.00 Anti-fibrotic drugs for Crohn’s? G. Rogler, Zurich

10.20 New anti-IL23 blockers M.C. Fantini, Rome

10.40 Coffee break with poster session

Session VI Tailoring surgery to patients

Chair: W.A. Bemelman, Amsterdam; Y. Panis, Clichy

11.10 Tailoring surgery in UC: Always proctocolectomy A. D’Hoore, Leuven

11.30 Tailoring surgery in CD A. Spinelli, Milan

11.50 Perianal Crohn‘s disease S. Steele, Cleveland

12.10 Perioperative medications M. Vecchi, Milan

12.30 Presentation of Poster Awards S. Danese, Milan

A. Dignass, Frankfurt

12.50 Lunch break with poster session

9

Saturday, October 6, 2018 Session VII

Challenging clinical scenarios Chair: A. Armuzzi, Rome; B.E. Sands, New York

14.00 Patient with previous cancer L. Beaugerie, Paris

14.20 A patient with previous opportunistic infections J. Lindsay, London

14.40 Crohn’s disease and tuberculosis in endemic areas F. Gomollón, Zaragoza

15.10 Fistulising CD: - Pro medical treatment P. Gionchetti, Bologna

- Pro surgical treatment P.G. Kotze, Curitiba

15.40 Closing remarks P. Gionchetti, Bologna

A. Armuzzi, Rome

10

Poster Abstracts1.* Crohn’s and ulcerative colitis questionnaire-8 (CUCQ-8), a valid and quick

quality of life measure in IBD L. Alrubaiy, P. Dodds, H. Hutchings, J.G. Williams (Swansea, GB)

L. Alrubaiy, I. Arnott, A. Protheroe, M. Roughton, J.G. Williams (Swansea, Edinburgh, London, GB)

3. Clinicians‘ knowledge about the ionizing radiation of the common

L. Alrubaiy, A. Rikaby, S. Al-Rubaye, C.L. Ch’ng (Swansea, London, GB)

P. Andreev, O. Davydova (Samara, RU)

M. Artom, W. Czuber-Dochan, J. Sturt, H. Proudfoot, C. Norton (London, GB)

G. Balci, H. Cetinkaya, A. Ensari (Ankara, TR)

ulcerative colitis

bowel disease N. Bibani, H. Jelassi, M. Sabbah, D. Trad, A. Ouakaa, H. Elloumi, D. Gargouri (Tunis, TN)

10. An association between anti-Saccharomyces cerevisiae antibodies (ASCA)

(Ankara, TR)

association

disease N. Blazevic, M. Nikolic, A. Muslim, M. Zivkovic, I. Budimir, A. Biscanin, D. Hrabar, Z. Dorosulic (Zagreb, HR)

Turkey

11

H. Cedron (Lima, PE)

Our 7 year outcomes and achievements

disease (PIBD) L. Cococcioni, O. Ogunmoye, S. Sider, R. Buckingham, S. Chadokufa,

colitis

I. Curlin, I. Romic (Dubrovnik, HR)

24. Characterising and managing issues with food-related quality of life in

(London, GB)

bowel diseases N. Danilova, M. Markelova, S. Abdulkhakov, T. Grigoryeva, A. Tyakht,

attack of ulcerative colitis O. Davydova, P. Andreev (Samara, RU)

(Bals, Craiova, RO)

12

I.-G. Diaconu (Bals, Craiova, RO)

(Bals, Craiova, RO)

and treatment

D. Neagoe (Craiova, Bals, RO)

diseases

D. Neagoe (Craiova, Bals, RO)

D. Neagoe (Craiova, Bals, RO)

disease under treatment

G. Cullen, G. Doherty, J. Sheridan (Dublin, IE)

N. Elleuch, W. Dahmani, H. Jaziri, A. Ben Slama, A. Hammami, A. Brahem,

H. Elloumi, M. Ben Hmida, A. Belkhamsa, S. Ben Hmida, S. Bouaziz, I. Cheikh (Bizerte, TN)

H. Elloumi, M. Ben Hmida, S. Bouaziz, A. Belkhamsa, S. Ben Hmida , I. Cheikh (Bizerte, TN)

under long-term mesalamine treatment

13

(Nizhny Novgorod, RU)

E. Fedulova (Nizhny Novgorod, RU)

age of onset

(Buenos Aires, AR)

H. Gdoura, A. Siala, M. Boudabous, L. Chtourou, A. Amouri, L. Mnif,

A. Badea (Craiova, Bals, RO)

women with endometriosis D. Gordienko (Rostov-on-Don, RU)

E. Gordienko (St. Petersburg, RU)

Y. Gu, Q. Wu, J. Zhong (Shanghai, CN)

M. Guney, M. Erdil, G. Basaranoglu, M. Basaranoglu (Istanbul, TR)

D. Habiba, M. Serguini, D. Saadouli, J. Boubaker (Tunis, TN)

L. Hamzaoui, H. Ayadi, M. Medhioub, A. Ben Mohamed, M. Mahmoudi,

(Nabeul, TN)

14

Crohn‘s disease

M.M. Azouz (Nabeul, TN)

acute ulcerative colitis in the CONSTRUCT trial H. Hutchings, L. Alrubaiy, A. Watkins, W.-Y. Cheung, A.C. Seagrove, I.T. Russel, J.G. Williams (Swansea, GB)

G. Iliescu, M. Cheie, G. Tene, A. Iordache, A. Neagoe (Craiova, RO)

colitis (UC)

H.E. Johnson, S. McLaughlin (Bournemouth, GB)

referral center

15

67. Protective effect of mesalazine on thromboembolic event risk in Crohn’s disease

(Ankara, TR)

69. Audit into the frequency of reactions to intravenous iron infusions

S. Bridger, J. Shutt (Dorchester, GB)

Z. Mahovne (Slavonski Brod, HR)

mucosal healing of ulcerative colitis

P. Radwan (Lublin, PL)

76. Colectomy-free survival and factors associated with it in children with ulcerative

R. Muhammed, S.-Y. Ong, W. Haller (Birmingham, GB)

16

necrosis factor antagonist failure A. Muslim, M. Nikolic, J. Muslim, M. Zivkovic, N. Blazevic, I. Budimir, Z. Dorosulic, D. Hrabar, A. Biscanin (Sisak, Zagreb, HR)

biomarkEr

S. Crowe (Cambridge, London, GB)

disease

treatment

H. Cetinkaya (Ankara, TR)

Osijek, Zadar, HR)

clinical situations

A.R. Sydorchuk, R.I. Sydorchuk (Chernivtsi, UA)

in Crohn’s disease

M. Razov Radas (Zadar, HR)

S. Reif, T. Oron (Jerusalem, Petah Tikva, IL)

17

treatment L. Rivas (Lima, PE)

90. Malnutrition in Tunisian Crohn‘s disease cohort H. Romdhane, B. Bouchabou, N. Bellil, H. Ben Nejma, R. Ennaifer (Tunis, TN)

H. Romdhane, B. Bouchabou, H. Ben Nejma, N. Bellil, R. Ennaifer (Tunis, TN)

C. Rowan, E. Brown, E. Ryan, C. Taylor, G. Doherty (Dublin, IE)

93. Risk factors for ocular involvement during Crohn‘s disease D. Saadouli, S. Yahyaoui, A. Sammoud, M.A. El Efrit (Tunis, TN)

D. Saadouli, S. Yahyaoui, A. Sammoud, M.A. El Efrit (Tunis, TN)

I. Sarvilina (Rostov-on-Don, RU)

bowel disease S. Shwana, I. Rikaby, L. Alrubaiy, M. Sageer, H. Hutchings, J.G. Williams

S. Shwana, I. Rikaby, L. Alrubaiy, H. Hutchings, J.G. Williams (Merthyr

M. Sladek, M. Chmielowska, A. Wasilewska, I. Herman-Sucharska,

storage disease 1B as an illustration M. Slae, M. Wilschanski (Jerusalem, IL)

M. Slae, P. Millman (Jerusalem, IL)

18

bowel disease L. Sweeney, R. Moss-Morris, W. Czuber-Dochan, L. Meade, G. Chumbley, C. Norton (London, GB)

I.I. Sydorchuk (Chernivtsi, UA)

L.P. Sydorchuk, P.D. Fomin, R.I. Sydorchuk, O.M. Plehutsa, I. Sydorchuk,

R.I. Sydorchuk, P.D. Fomin, O.M. Plehutsa, L.P. Sydorchuk, I.I. Sydorchuk,

(Szeged, Debrecen, HU)

I. Tadin Hadjina, P.M. Zivkovic, A. Matetic, J.A. Borovac, J. Bukic, D. Rusic,

M. Tagle, Y. Scavino, E. Luna (Lima, PE)

R. Tamburic, J. Petkovic-Dabic, T. Barac, A. Dobrovoljski, S. Dabic, S. Trbojevic (Banja Luka, BA)

G.N. Tarasova, L. Mamedova (Rostov-on-Don, RU)

112. The role of stool genetic testing (SGT) for differential diagnosis of early stage IBD and IBS

(Bialystok, PL)

19

(CONSTRUCT) J.G. Williams, A. Rikaby, M.F. Alam, L. Alrubaiy, I. Arnott, C. Clement, D. Cohen, J.N. Gordon, A.B. Hawthorne, M. Hilton, H. Hutchings, A. Jawhari, M. Longo,

Shor, S. Neuman, N. Levhar, E. Fudim, B. Avidan, L. Selinger, N. Orbach, O. Picard, M. Yavzori, A.R. Eliakim, S. Ben-Horin (Tel Aviv, IL)

and increased CRP in ulcerative colitis

ska-Ustymowicz, A. Pryczynicz (Bialystok, PL)

* = Posters of Distinction

20

List of Speakers, Moderators and Scientific Organizers

Prof. Dr. Matthieu AllezService de GastroentérologieHôpital Saint-Louis1 Ave. C. Vellefaux75010 ParisFrancematthieu.allez@aphp.fr

Dr. Vito AnneseValiant ClinicCity Walk, 13th StreetP.O. Box 414296 DubaiUnited Arab Emiratesvitoannese1@gmail.com

Dr. Alessandro ArmuzziIBD UnitFondazione Policlinico GemelliComplesso Integrato ColumbusUniversità CattolicaVia Moscati, 31-3300168 RomeItalyalessandro.armuzzi@unicatt.it

Prof. Dr. Raja AtreyaMedizinische Klinik IUniversitätsklinikum ErlangenUlmenweg 1891054 ErlangenGermanyraja.atreya@uk-erlangen.de

Dr. Filip BaertGastro-enterologieAZ Delta Campus WilgenstraatWilgenstraat 28800 RoeselareBelgiumfilip.baert@azdelta.be

Prof. Dr. Laurent BeaugerieDepartment of GastroenterologyHôpital Saint Antoine184, Rue du Faubourg St.-Antoine75571 ParisFrancelaurent.beaugerie@sat.aphp.fr

Prof. Dr. Willem A. BemelmanDepartment of SurgeryUniv. van Amsterdam, Tytgat Institutefor Liver & Intestinal ResearchMeibergdreef 91105 AZ Amsterdam The Netherlandsw.a.bemelman@amc.uva.nl

Dr. Stefanos BonovasDepartment of GastroenterologyIstituto Clinico HumanitasHumanitas UniversityVia Manzoni 56 20089 RozzanoItalysbonovas@gmail.com

Prof. Dr. Franck CarbonnelService d‘HépatogastroentérologieCHU de BicêtreUniversité Paris Sud78 rue du Général Leclerc94275 Le Kremlin-BicêtreFrancefranck.carbonnel@bct.aphp.fr

Dr. Yehuda ChowersDepartment of GastroenterologyRambam Medical CenterP.O. Box 960231096 HaifaIsraely_chowers@rambam.health.gov.il

21

Prof. Dr. Silvio DaneseIRCCS in GastroenterologyIstituto Clinico Humanitas IRCCSVia Manzoni 5620089 RozzanoItalysdanese@hotmail.com

Dr. Marco DapernoGastroenterology UnitMauriziano HospitalLargo Turati 6210128 TurinItalymdaperno@gmail.com

Prof. Dr. André D‘HooreDepartment Abdominal SurgeryUniversity Hospital LeuvenHerestraat 493000 LeuvenBelgiumandre.dhoore@uz.kuleuven.ac.be

Prof. Dr. Axel DignassMedizinische Klinik IAGAPLESIONMarkus KrankenhausWilhelm-Epstein-Str. 460431 FrankfurtGermanyaxel.dignass@fdk.info

Prof. Dr. Iris DotanDivision of GastroenterologyRabin Medical CenterBeilinson Hospital39 Jabotinski St.49100 Petah TikvaIsraelirisdo@clalit.org.il

Marla C. Dubinsky, M.D.Professor of PediatricsThe Susan & Leonard FeinsteinIBD Clinical Center 17 East 102nd Street, 5th Floor New York, NY 10029USAmarla.dubinsky@mssm.edu

Prof. Dr. Massimo C. FantiniDepartment of System MedicineUnit of GastroenterologyEd.E-Sud, Lab. E33University of Rome „Tor Vergata“Via Montpellier 100133 RomeItalym.fantini@med.uniroma2.it

Dr. Brian G. FeaganRobarts Clinical Trials Inc100 Dundas Street, Suite 200London, ON N6A 5B6Canadabrian.feagan@robartsinc.com

Prof. Dr. Marc FerranteGastroenterology and HepatologyUniversity Hospital LeuvenHerestraat 493000 LeuvenBelgiummarc.ferrante@uzleuven.be

Claudio Fiocchi, M.D.Professor of MedicinePathobiology / NC 20The Cleveland Clinic Foundation9500 Euclid AvenueCleveland, OH 44195USAfiocchc@ccf.org

Dr. Gionata FiorinoIRCCS in GastroenterologyIstituto Clinico Humanitas IRCCSVia Manzoni 5620089 RozzanoItalygionataf@gmail.com

Prof. Dr. Subrata GhoshInstitute of Translational MedicineUniversity of BirminghamBirmingham B15 2TTGreat Britainghoshs@bham.ac.uk

22

Prof. Dr. Paolo GionchettiIstituto di Clinica e GastroenterologiaPoliclinico S. OrsolaUniversità di BolognaVia Massarenti 940138 BolognaItalypaolo.gionchetti@unibo.it

Dr. Fernando GomollónHospital Clinico UniversitarioLosano BlesaAvenida San Juan Bosco 1550009 ZaragozaSpainfgomollon@gmail.com

Dr. Paulo G. KotzeIBD Outpatient ClinicCatholic University of ParanáAv. Sao Jose, 300 - CEP 80050-350CuritibaBrazilpgkotze@hotmail.com

Prof. Dr. James LindsayConsultant GastroenterologistBart‘s Health NHS TrustThe Royal London HospitalLondon E1 1BBGreat Britainjames.lindsay@bartshealth.nhs.uk

Prof. Dr. Edouard LouisGastro-entérologieC.H.U. Sart TilmanDomain du Sart Tilman4000 LiègeBelgiumedouard.louis@ulg.ac.be

Prof. Dr. Fernando J. MagroServico de GastroenterologiaHospital de S. JoaoAv. Prof. Hernani Monteiro4200-319 PortoPortugalfm@med.up.pt

Prof. Dr. Remo PanaccioneInflammatory Bowel Disease ClinicRoom 6D30, TRW BuildingUniversity of Calgary3280 Hospital Drive N.W.Calgary, AB T2N 2T9Canadarpanacci@ucalgary.ca

Prof. Dr. Yves PanisService de Chirurgie ColorectaleHôpital Beaujon100, Bd. Général Leclerc92118 ClichyFranceyves.panis@bjn.aphp.fr

Prof. Dr. Fernando RizzelloDipartimento di Scienze Mediche e ChirurgicheS. Orsola-Malpighi HospitalUniversita di BolognaVia Massarenti 940138 BolognaItalyfernando.rizzello@unibo.it

Prof. Dr. Dr. Gerhard RoglerKlinik für Gastroenterologie& HepatologieUniversitätsspital ZürichRämistr. 1008091 ZürichSwitzerlandgerhard.rogler@usz.ch

William J. Sandborn, M.D. Professor of MedicineDivision of GastroenterologyUniversity of California 9500 Gilman Drive, MC 0956La Jolla, CA 92093USAwsandborn@ucsd.edu

23

Bruce E. Sands, M.D.Professor of MedicineDepartment of GastroenterologyMount Sinai School of MedicineOne Gustave L. Levy PlaceNew York, NY 10029USAbruce.sands@mssm.edu

Prof. Dr. Stefan SchreiberKlinik für Innere Medizin IUniversitätsklinikumSchleswig-Holstein, Campus KielArnold-Heller-Str. 3 (Haus 6)24105 KielGermanys.schreiber@mucosa.de

Prof. Dr. Britta SiegmundMed. Klinik für Gastroenterologie, Infektiologie und RheumatologieCampus Benjamin Franklin (CBF)Charité UniversitätsmedizinHindenburgdamm 3012203 BerlinGermanybritta.siegmund@charite.de

Prof. Dr. Antonino SpinelliUnità Operativa di Chirurgia Generale IIIIstituto Clinico Humanitas IRCCSVia Manzoni 5620089 RozzanoItalyantonino.spinelli@humanitas.it

Scott Steele, M.D.Colorectal SurgeryCleveland Clinic Main CampusMail Code A309500 Euclid AvenueCleveland, OH 44195USAsteeles3@ccf.org

Prof. Dr. Andreas SturmInnere Medizin/GastroenterologieDRK-Kliniken WestendSpandauer Damm 13014050 BerlinGermanya.sturm@drk-kliniken-berlin.de

Dr. Simon P.L. TravisDepartment of GastroenterologyOxford University HospitalsOxford OX3 9DUGreat Britainsimon.travis@ndm.ox.ac.uk

Prof. Dr. Maurizio VecchiUniversity of Milan - IRCCSCa‘ Granda Ospedale MaggiorePoliclinico FoundationGastroenterology UnitVia Francesco Sforza 3520122 MilanoItalymaurizio.vecchi@unimi.it

24

Congress OfficeDuring Symposium 213

Congress Office Telephone: +49-175-7795-327

Opening Hours:Thursday, October 4, 2018 16.00 – 21.00 hFriday, October 5, 2018 8.00 – 18.00 hSaturday, October 6, 2018 8.30 – 16.00 h

Milan Marriott HotelVia Washington 6620146 MilanItaly

Admission to Scientific ProgramFor admission to scientific events your name badge should be clearly visible.

Conflicts of Interest Members of the scientific committee declare the following potential conflicts of interest:Alessandro Armuzzi: MSD, AbbVie, Allergan, Biogen, Celgene, Celltrion, Ferring, Hospira, Janssen, Lilly, Mundipharma, Pfizer, Samsung Bioepis, Sofar, Takeda, AstraZeneca, Chiesi, Medtronic, Mistsubishi Tanabe, Nikkiso, Otsuka, Tigenix, Zambon; Silvio Danese: AbbVie, Ferring, Hospira, Johnson and Johnson, Merck, MSD, Takeda, Mundipharma, Pfizer, Tigenix, UCB Pharma, Vifor, Biogen, Celgene, Allergan, Celltrion, Sandoz, Boehringer Ingelheim; Axel Dignass: Abbvie, MSD, Ferring, Roche, Takeda, Pharmacosmos, Vifor, Falk Pharma, Mundipharma, Janssen, Hospira, Robarts, Pfizer, Sandoz, Celgene, Tillotts, Falk Foundation, Otsuka, Immundiagnostik, Med Update GmbH, Medice, Wiley, Thieme, Allergosan, Pharmacosmos; Paolo Gionchetti: Janssen, Abbvie, Pfizer, Celgene, Takeda, Ferring, MSD, Alfa Wasserman, Amgen, Sofar, Chiesi

25

AirportMilano Malpensa AirportDistance to hotel: 49 km; Taxi fare approx.: EUR 90http://www.milanomalpensa-airport.com/en

Linate AirportDistance to hotel: 12 km; Taxi fare approx.: EUR 35http://www.milanolinate-airport.com/en

Orio al Serio International AirportDistance to hotel: 55 km; Taxi fare approx.: EUR 100http://www.milanbergamoairport.it/en/

ParkingThe hotel offers parking spaces on first come first serve basis. (2,10€ hourly, 15€ daily)

2019

International Symposia and Workshops

Scientific Dialogue in the Interest of Therapeutic Progress

Symposium 216Building Bridges in IBDBrussels, BelgiumSeptember 13–14, 2019

Symposium 217West Meets East:Functional Meets Organic Gastrointestinal DiseasesSingaporeNovember 29–30, 2019

WorkshopFrom Viral Hepatitis to ChronicInflammation and Liver CancerHeidelberg, GermanyFebruary 21–22, 2019

Symposium 214IBD: From Pathophysiology to Personalized MedicineOxford, Great BritainMarch 29–30, 2019

Symposium 215IBD: From Diagnosis to TherapySt. Petersburg, RussiaJuly 5–6, 2019

Congress DepartmentTel.: +49 (0)761/1514-125Fax: +49 (0)761/1514-359E-Mail: symposia@falk-foundation-symposia.orgwww.falk-foundation-symposia.org

P213

1-9

/201

8/ 1

.00

0 St

ü

Organized by:

FALK FOUNDATION e.V.Leinenweberstr. 579108 FreiburgGermany

Congress DepartmentTel.: +49–761–1514–125Fax: +49–761–1514–359E-Mail: symposia@falk-foundation-symposia.orgwww.falk-foundation-symposia.org